368 related articles for article (PubMed ID: 27296521)
41. Molecular mechanisms of inherited cardiomyopathies.
Fatkin D; Graham RM
Physiol Rev; 2002 Oct; 82(4):945-80. PubMed ID: 12270949
[TBL] [Abstract][Full Text] [Related]
42. Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.
Schick R; Mekies LN; Shemer Y; Eisen B; Hallas T; Ben Jehuda R; Ben-Ari M; Szantai A; Willi L; Shulman R; Gramlich M; Pane LS; My I; Freimark D; Murgia M; Santamaria G; Gherghiceanu M; Arad M; Moretti A; Binah O
PLoS One; 2018; 13(10):e0205719. PubMed ID: 30332462
[TBL] [Abstract][Full Text] [Related]
43. Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy.
Silva Dos Santos D; Brasil GV; Ramos IPR; Mesquita FCP; Kasai-Brunswick TH; Christie MLA; Cahli GM; Barbosa RAQ; da Cunha ST; Pereira JX; Medei E; Campos de Carvalho AC; Carvalho AB; Goldenberg RCDS
Stem Cell Res Ther; 2018 Feb; 9(1):30. PubMed ID: 29402309
[TBL] [Abstract][Full Text] [Related]
44. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
45. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.
Gnecchi M; Stefanello M; Mura M
Int J Cardiol; 2017 Jun; 237():49-52. PubMed ID: 28408106
[TBL] [Abstract][Full Text] [Related]
46. Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.
Zhang L; Guo J; Zhang P; Xiong Q; Wu SC; Xia L; Roy SS; Tolar J; O'Connell TD; Kyba M; Liao K; Zhang J
Circ Heart Fail; 2015 Jan; 8(1):156-66. PubMed ID: 25420485
[TBL] [Abstract][Full Text] [Related]
47. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
[TBL] [Abstract][Full Text] [Related]
48. Steps toward safe cell therapy using induced pluripotent stem cells.
Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
[TBL] [Abstract][Full Text] [Related]
49. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Bezzerides VJ; Zhang D; Pu WT
Circ J; 2016 Dec; 81(1):12-21. PubMed ID: 27916777
[TBL] [Abstract][Full Text] [Related]
50. Generation and cardiac differentiation of an induced pluripotent stem cell line from a patient with arrhythmia-induced cardiomyopathy.
Rebs S; Beier J; Argyriou L; Schill T; Hasenfuss G; Vollmann D; Sossalla S; Streckfuss-Bömeke K
Stem Cell Res; 2021 May; 53():102263. PubMed ID: 33631417
[TBL] [Abstract][Full Text] [Related]
51. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.
Rikhtegar R; Pezeshkian M; Dolati S; Safaie N; Afrasiabi Rad A; Mahdipour M; Nouri M; Jodati AR; Yousefi M
Biomed Pharmacother; 2019 Jan; 109():304-313. PubMed ID: 30396088
[TBL] [Abstract][Full Text] [Related]
52. Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome-Associated Cardiomyopathy.
Hanses U; Kleinsorge M; Roos L; Yigit G; Li Y; Barbarics B; El-Battrawy I; Lan H; Tiburcy M; Hindmarsh R; Lenz C; Salinas G; Diecke S; Müller C; Adham I; Altmüller J; Nürnberg P; Paul T; Zimmermann WH; Hasenfuss G; Wollnik B; Cyganek L
Circulation; 2020 Sep; 142(11):1059-1076. PubMed ID: 32623905
[TBL] [Abstract][Full Text] [Related]
53. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias.
Ohiri JC; Dellefave-Castillo L; Tomar G; Wilsbacher L; Choudhury L; Barefield DY; Fullenkamp D; Gacita AM; Monroe TO; Pesce L; Blancard M; Vaught L; George AL; Demonbreun AR; Puckelwartz MJ; McNally EM
J Am Heart Assoc; 2024 May; 13(10):e030467. PubMed ID: 38761081
[TBL] [Abstract][Full Text] [Related]
54. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
55. Induced pluripotent stem-cell-derived cardiomyocytes: cardiac applications, opportunities, and challenges.
Moreau A; Boutjdir M; Chahine M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1108-1116. PubMed ID: 28350968
[TBL] [Abstract][Full Text] [Related]
56. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.
Jung JH; Fu X; Yang PC
Circ Res; 2017 Jan; 120(2):407-417. PubMed ID: 28104773
[TBL] [Abstract][Full Text] [Related]
57. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
[TBL] [Abstract][Full Text] [Related]
58. Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Rhee JW; Yi H; Thomas D; Lam CK; Belbachir N; Tian L; Qin X; Malisa J; Lau E; Paik DT; Kim Y; Choi BS; Sayed N; Sallam K; Liao R; Wu JC
Cell Rep; 2020 Jul; 32(2):107886. PubMed ID: 32668256
[TBL] [Abstract][Full Text] [Related]
59. Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.
Karakikes I; Stillitano F; Nonnenmacher M; Tzimas C; Sanoudou D; Termglinchan V; Kong CW; Rushing S; Hansen J; Ceholski D; Kolokathis F; Kremastinos D; Katoulis A; Ren L; Cohen N; Gho JMIH; Tsiapras D; Vink A; Wu JC; Asselbergs FW; Li RA; Hulot JS; Kranias EG; Hajjar RJ
Nat Commun; 2015 Apr; 6():6955. PubMed ID: 25923014
[TBL] [Abstract][Full Text] [Related]
60. Future prospects for regenerated heart using induced pluripotent stem cells.
Fujita J; Fukuda K
J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
